Form 4: Director Thomas Lehrman Sells Ibotta Shares

Director Thomas Lehrman reported the sale of Ibotta, Inc. Class A Common Stock across multiple transactions between May 15 and May 18, 2026.

Summary

• Director Thomas D. Lehrman executed several sales of Ibotta, Inc. Class A Common Stock.
• The transactions occurred between May 15, 2026, and May 18, 2026.
• Sales involved a total of 182 shares at a weighted average price of $31.5927, 18,307 shares at a weighted average price of $30.7785, 12,025 shares at a weighted average price of $32.1063, and 11,812 shares at a weighted average price of $30.7785, and 7,763 shares at a weighted average price of $32.1064.
• Following these transactions, Lehrman beneficially owns 51,141 shares indirectly through LFP 2, LLC and 40,744 shares indirectly through Four Ways, LLC, in addition to other direct holdings.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to the director's significant stock sales, which could be interpreted as a lack of confidence, although the exact reasons are not provided.

Negatives

• Director Thomas D. Lehrman has sold a significant number of shares.
• The sales occurred over a short period, indicating a potential divestment.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. Significant sales by directors can sometimes signal a lack of confidence in future stock performance, though they can also be for personal financial planning.

Stakeholder Impact

• Shareholders may view the director's sales negatively, potentially impacting share price due to reduced insider confidence.
• The sales do not appear to directly impact employees, customers, suppliers, or creditors based on the information provided.

Key Dates

Recommendation

The filing reports insider sales by a director, which warrants attention. However, without further context on the reasons for the sales or the company's overall financial health and future prospects, a 'hold' recommendation is prudent. Investors should monitor future filings and company performance.

Keywords

Ibotta Inc, Form 4, SEC Filing, Insider Trading, Stock Sale, Director Transaction, Class A Common Stock, Thomas D. Lehrman